JP7541674B2 - 大動脈瘤の予防および治療用医薬組成物および加工食品 - Google Patents

大動脈瘤の予防および治療用医薬組成物および加工食品 Download PDF

Info

Publication number
JP7541674B2
JP7541674B2 JP2022568342A JP2022568342A JP7541674B2 JP 7541674 B2 JP7541674 B2 JP 7541674B2 JP 2022568342 A JP2022568342 A JP 2022568342A JP 2022568342 A JP2022568342 A JP 2022568342A JP 7541674 B2 JP7541674 B2 JP 7541674B2
Authority
JP
Japan
Prior art keywords
aortic aneurysm
preventing
group
abdominal aortic
aortic aneurysms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022568342A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022124390A1 (cg-RX-API-DMAC7.html
Inventor
信宏 財満
裕菜 久後
幹浩 北野
益教 廣田
賢一 平野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YASHIRO CO., LTD.
Kindai University
The University of Osaka
Original Assignee
YASHIRO CO., LTD.
Osaka University NUC
Kindai University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YASHIRO CO., LTD., Osaka University NUC, Kindai University filed Critical YASHIRO CO., LTD.
Publication of JPWO2022124390A1 publication Critical patent/JPWO2022124390A1/ja
Application granted granted Critical
Publication of JP7541674B2 publication Critical patent/JP7541674B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seasonings (AREA)
JP2022568342A 2020-12-11 2021-12-10 大動脈瘤の予防および治療用医薬組成物および加工食品 Active JP7541674B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020206109 2020-12-11
JP2020206109 2020-12-11
PCT/JP2021/045475 WO2022124390A1 (ja) 2020-12-11 2021-12-10 大動脈瘤の予防および治療用医薬組成物および加工食品

Publications (2)

Publication Number Publication Date
JPWO2022124390A1 JPWO2022124390A1 (cg-RX-API-DMAC7.html) 2022-06-16
JP7541674B2 true JP7541674B2 (ja) 2024-08-29

Family

ID=81974561

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022568342A Active JP7541674B2 (ja) 2020-12-11 2021-12-10 大動脈瘤の予防および治療用医薬組成物および加工食品

Country Status (4)

Country Link
US (2) US20240065992A1 (cg-RX-API-DMAC7.html)
EP (1) EP4260851A4 (cg-RX-API-DMAC7.html)
JP (1) JP7541674B2 (cg-RX-API-DMAC7.html)
WO (1) WO2022124390A1 (cg-RX-API-DMAC7.html)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004022051A1 (ja) 2002-09-05 2004-03-18 The Nisshin Oillio Group, Ltd. ペルオキシソーム増殖薬活性化受容体調整剤
WO2011007565A1 (ja) 2009-07-15 2011-01-20 国立大学法人浜松医科大学 PPARγ阻害剤を用いる動脈瘤の予防および治療
WO2015050071A1 (ja) 2013-10-01 2015-04-09 日本水産株式会社 栄養補助剤及び心血管疾患改善剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012235715A (ja) 2011-05-10 2012-12-06 Hamamatsu Univ School Of Medicine 大動脈瘤モデル動物
JP7236119B2 (ja) * 2019-06-21 2023-03-09 学校法人近畿大学 大動脈瘤の予防用医薬組成物および加工食品

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004022051A1 (ja) 2002-09-05 2004-03-18 The Nisshin Oillio Group, Ltd. ペルオキシソーム増殖薬活性化受容体調整剤
WO2011007565A1 (ja) 2009-07-15 2011-01-20 国立大学法人浜松医科大学 PPARγ阻害剤を用いる動脈瘤の予防および治療
WO2015050071A1 (ja) 2013-10-01 2015-04-09 日本水産株式会社 栄養補助剤及び心血管疾患改善剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Bioscience, Biotechnology, and Biochemistry,2016年,80(6),pp.1186-1191,DOI:10.1080/09168451.2016.1146073

Also Published As

Publication number Publication date
US20240065992A1 (en) 2024-02-29
JPWO2022124390A1 (cg-RX-API-DMAC7.html) 2022-06-16
EP4260851A4 (en) 2024-10-23
US20260207537A1 (en) 2026-07-23
EP4260851A1 (en) 2023-10-18
WO2022124390A1 (ja) 2022-06-16

Similar Documents

Publication Publication Date Title
US20260137641A1 (en) Pharmaceutical composition for aortic aneurysm prophylaxis and processed food
KR20200095255A (ko) 오메가 지방산을 포함하는 약학 조성물 및 이를 포함하는 수액제제
US20210330625A1 (en) Lipid formulations containing bioactive fatty acids
JP2015180640A (ja) バイオオイル組成物、上記オイル組成物を含む製剤と、循環器疾患の予防又は治療のためのその使用
US6310100B1 (en) Method of treating hypertension
US9808437B2 (en) Monounsaturated fatty acid compositions and use for treating atherosclerosis
CN103476405A (zh) 舒张性充血性心力衰竭治疗剂
BE876563A (fr) Acide gras et ses derives pour le traitement ou la prophylaxie des etats thrombo-emboliques
WO2022124390A1 (ja) 大動脈瘤の予防および治療用医薬組成物および加工食品
WO2007039945A1 (ja) 脂質代謝改善用組成物
EP2090176B1 (en) Postprandial hyperglycemia-improving agent
JP5504405B2 (ja) 血管病予防に効果を有する食品組成物
JP2006306813A (ja) 肥満細胞増殖抑制剤
JP6084319B2 (ja) インスリン分泌促進用食品
WO2008072385A1 (ja) 体脂肪の蓄積に起因する疾患の治療剤
JP4852296B2 (ja) 血管炎症候群予防・治療剤
JP4520623B2 (ja) 低血圧症予防・治療剤
JPWO2004022051A1 (ja) ペルオキシソーム増殖薬活性化受容体調整剤
WO2025053011A1 (ja) 産褥期のメンタル改善剤及びこれを含有する機能性食品
JP5787615B2 (ja) 左室拡張機能障害治療剤
Zou Attenuation of Cardiac Fibrillation Vulnerability by n-3 Polyunsaturated Fatty Acids in a Rat Model of Cardiomyopathy
JP2010120861A (ja) 血圧降下物質
PL221332B1 (pl) Zastosowanie oleju zawierającego kwas dokozaheksaenowy DHA do wytwarzania leku (54) przeznaczonego do leczenia patologii mięśnia sercowego wtórnych do przeciążenia ciśnieniowego i/lub objętościowego
WO2008153220A1 (ja) 血管疾患の予防又は治療剤
WO2012073965A1 (ja) インスリン分泌促進剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230331

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230331

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240326

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240509

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240730

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240806

R150 Certificate of patent or registration of utility model

Ref document number: 7541674

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150